H.C. Wainwright raised the firm’s price target on Anixa Biosciences to $12 from $11 and keeps a Buy rating on the shares post the fiscal Q1 results.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ANIX:
H.C. Wainwright raised the firm’s price target on Anixa Biosciences to $12 from $11 and keeps a Buy rating on the shares post the fiscal Q1 results.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ANIX: